Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
    • Transkriptioner
  • InderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet

Du verkar använda en bredare skärm. Vill du aktivera en bredare visningsupplevelse på denna sida?

Columbus – Presentation of interim report Q2 2025

Av HC Andersen Capital
Columbus

You can already now sign up for the event and send in your questions. You don’t have to participate live to submit questions for the event.

Columbus expects to release its Q2 2025 interim report on 21 August 2025. On 25 August at 11:00 AM, Columbus’ CEO & President Søren Krogh Knudsen and CFO Brian Iversen will present the results and answer questions from the audience during a live online event.

In Q1 2025, Columbus reported a revenue of DKK 434m, corresponding to a decline of -2% due to the uncertain macroeconomic environment. EBITDA amounted to DKK 46m in the quarter, corresponding to 10.7% margin (a significant improvement from 7.9% in Q1 2024 after adjusting for the M3CS legal case). Columbus maintained its full year guidance for 2025, which is organic revenue growth of 7-9% and EBITDA margin in the range of 10-12%. In addition to the financial results for Q2 2025, management comments on the current market outlook may be a key focus at the investor event.

Columbus is a Danish-listed global IT services and consulting company, specializing in digital transformation with a main focus in the manufacturing, retail & distribution, food & beverage, and life science industries. Headquartered in Denmark and with offices and partners across many parts of the world, Columbus advises, implements, and manages IT solutions within the areas Dynamics 365, M3, Digital Commerce, Data & AI, and Other Local Business. The Columbus share is listed on Nasdaq Copenhagen (Ticker: COLUM).

Disclaimer: HC Andersen Capital receives payment from Columbus for a Digital IR subscription agreement. /Kasper Lihn 10.18, 7 July 2025.

Recent videos

Herantis Pharma Plc, Phase 1b biomarker data webcast
2026-01-08 11:00 Herantis Pharma
Investor Day | Nov. 24, 2025
2025-12-23 11:00 United Bankers
Uppesittarkväll 22/12 från Inderes Event Studio
2025-12-22 20:00
Talenom - Planned demerger and strategies of Talenom and Easor
2025-12-18 11:00 Talenom
Conference call with Fabege´s new CEO Bent Oustad
2025-12-18 10:00 Fabege
Titta på alla videos
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.